Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal Membrane Oxygenation

NCT07352072 · tracked via the Priya Life Science Denmark tracker

Sponsor

Copenhagen University Hospital, Rigshospitalet

Phase

Observational

Started

2026-01

Last updated

2026-01-29

Condition(s) studied

VV ECMOBleedingThrombosisTransfusion Adverse ReactionCOVID-19

Study summary

The investigators aim to assess the risk of bleeding and thrombo-embolic complications as well as benefit and harm of blood product transfusion and anticoagulation therapy in adult ICU patients with COVID-19 supported with V-V ECMO

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion criteria: * Adults * Polymerase chain reaction (PCR) verified COVID-19 infection * Supported with V-V ECMO in this center Exclusion criteria: \- none

Primary outcome measure(s)

Bleeding events — 90 days
A bleeding event is defined as any event requiring at least 3 units of red blood cells within 24 hours or transfusion with 3 or more units of either fresh frozen plasma, platelet concentrates or red blood cells within 24 hours, any intracranial bleeding or bleeding requiring invasive/surgical interventions

Trial sites (1)

Facility	City	Region	Status
Department of cardiothoracic anaesthsia and intensive care 4141	Copenhagen	Denmark

More Copenhagen University Hospital, Rigshospitalet trials in Denmark

The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events Active, not recruiting

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion Recruiting

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions Recruiting

The 3rd COPENHAGEN Puberty Study Recruiting

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer Recruiting

Other trials for the same condition

Post-acute COVID-19 Sequelae in Denmark Recruiting

Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury Active, not recruiting

Amplatzer Amulet LAAO vs. NOAC Active, not recruiting

CHAMPION-AF Clinical Trial Active, not recruiting

The Nasal Microbiome and Its Importance in Disease Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07352072 on ClinicalTrials.gov ↗ ← All trials in Denmark